Gender Disparities in Treatment
A stark contrast emerges in the treatment protocols for men and women regarding hormone-blocking therapies. While men often see reduced treatment durations due to severe side effects, women are frequently prescribed longer courses, raising concerns about gender bias in medical practices. The discussion highlights the need for a reevaluation of how hormone therapies are approached, emphasizing the importance of ongoing scientific inquiry to uncover the best practices for both genders.In this clip
From this podcast
The Dr Louise Newson Podcast
138 - Explaining what the evidence shows to offer choice to women after breast cancer, with Avrum Bluming
Related Questions